Studies in thyroid cancer cell lines show that silencing H19 decreased cell viability and increased apoptosis in these cells, and correlated with decreased levels of phosphorylation of PI3K and AKT, suggesting decreased activity of the pathway. This evidence concerns the gene H19 and thyroid cancer.